IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Introgen Therapeutics Inc

Q2 2015 vs Q4 2015

Comparing institutional holders between quarters

Quarters

Q4 2015Q2 2015Q4 2013Q3 2013Q2 2013
CompareDetailedHistoricalFundsOptions13D/13GPeersTargetingTrading SummaryProfile
Beck Capital Management, LLC
UNCHANGED
Shares26,000 from 26,000
Change0 (0%)
Value$0 ($0)
Filed 2016-02-12
Status
Beck Capital Management, LLC
UNCHANGED26,00026,00000%$0$0$02016-02-12
Showing 1 of 1 institutions